The document shows the levered and unlevered betas, debt to equity ratios, and net sales for 15 pharmaceutical companies in India. On average, the unlevered betas for the companies are 0.56, while the average debt to equity ratio is 0.67. Cipla Limited has the highest net sales of Rs. 12374.01 crores and the lowest levered beta of 0.71.
The document shows the levered and unlevered betas, debt to equity ratios, and net sales for 15 pharmaceutical companies in India. On average, the unlevered betas for the companies are 0.56, while the average debt to equity ratio is 0.67. Cipla Limited has the highest net sales of Rs. 12374.01 crores and the lowest levered beta of 0.71.
The document shows the levered and unlevered betas, debt to equity ratios, and net sales for 15 pharmaceutical companies in India. On average, the unlevered betas for the companies are 0.56, while the average debt to equity ratio is 0.67. Cipla Limited has the highest net sales of Rs. 12374.01 crores and the lowest levered beta of 0.71.